115 related articles for article (PubMed ID: 1347157)
21. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
[No Abstract] [Full Text] [Related]
22. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
Binder RL; Jonelis FJ
Arch Dermatol; 1983 Jun; 119(6):473-5. PubMed ID: 6134496
[TBL] [Abstract][Full Text] [Related]
23. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
24. Deconstructing a medication regimen.
Preskorn SH
J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
[No Abstract] [Full Text] [Related]
25. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
Sandyk R; Kay SR
Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
[TBL] [Abstract][Full Text] [Related]
26. [Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
Cohen D; Diemont WL
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1942-4. PubMed ID: 12404911
[TBL] [Abstract][Full Text] [Related]
27. Drugs inducing or aggravating parkinsonism: a review.
Marti-Massó JF; Poza JJ; Lopez de Munain A
Therapie; 1996; 51(5):568-77. PubMed ID: 9138399
[TBL] [Abstract][Full Text] [Related]
28. [Neuroleptics in psychogeriatrics. Evaluation of a treatment proposal].
Willekens-Bogaers MA; Smits GW
Tijdschr Gerontol Geriatr; 1990 Jul; 21(3):99-107. PubMed ID: 1974367
[TBL] [Abstract][Full Text] [Related]
29. Stevens-Johnson syndrome in neuroleptic-carbamazepine combination.
Wong KE
Singapore Med J; 1990 Oct; 31(5):432-3. PubMed ID: 1979691
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series.
Masui T; Kusumi I; Takahashi Y; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):343-6. PubMed ID: 15694245
[TBL] [Abstract][Full Text] [Related]
31. HLA antigens in drug-induced parkinsonism.
Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S
Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491
[TBL] [Abstract][Full Text] [Related]
32. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
[TBL] [Abstract][Full Text] [Related]
33. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
Hausner RS
J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
[TBL] [Abstract][Full Text] [Related]
34. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
Mukherjee S; Debsikdar V
Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
[TBL] [Abstract][Full Text] [Related]
35. Risperidone-induced tardive dyskinesia and parkinsonism.
Gwinn KA; Caviness JN
Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
[No Abstract] [Full Text] [Related]
36. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
[No Abstract] [Full Text] [Related]
37. Neuroleptic-induced parkinsonism: impaired potentiation of the H-reflexes.
Bartels M; Maltzahn DV; Mezger G
Electromyogr Clin Neurophysiol; 1982; 22(1-2):9-20. PubMed ID: 6121699
[No Abstract] [Full Text] [Related]
38. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
39. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Bitton V; Melamed E
J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
